Fortrea To Present At The Evercore Healthconx Conference
Date
11/26/2024 4:31:13 PM
(MENAFN- GlobeNewsWire - Nasdaq) DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief financial Officer, Jill McConnell will present at the Evercore HealthCONx conference on Thursday, December 5, 2024 at 10:00 am ET.
The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website . A webcast replay will be available after the event.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts:
Hima Inguva (Investors) – 877-495-0816, ...
Sue Zaranek (Media) – 919-943-5422, ...
Kate Dillon (Media) – 646-818-9115, ...
MENAFN26112024004107003653ID1108929549
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.